Allergic and Irritant Contact Dermatitis
Eczematous reaction from skin contact with chemical irritants (ICD) or allergens triggering type IV hypersensitivity (ACD).
Also known as: contact dermatitis, allergic contact dermatitis, irritant contact dermatitis, ACD, ICD, poison ivy
Overview
Inflammatory dermatitis caused by direct contact with an exogenous agent. Two main forms: irritant contact dermatitis (ICD, non-immunologic toxic injury) and allergic contact dermatitis (ACD, T-cell mediated type IV delayed hypersensitivity).
Epidemiology
ICD accounts for ~80% of all contact dermatitis; most common occupational skin disease (hairdressers, healthcare, cleaning, construction, food handling). ACD prevalence ~20%; nickel is the most common allergen worldwide.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Allergic and Irritant Contact Dermatitis outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- Occupational wet work, frequent hand washing, hand sanitizers
- Atopic dermatitis (impaired barrier → predisposes to ICD and sensitization)
- Common allergens: nickel, fragrance mix, balsam of Peru, formaldehyde, preservatives (MCI/MI, paraben mix), neomycin, bacitracin, rubber accelerators, p-phenylenediamine (hair dye), urushiol (Toxicodendron — poison ivy/oak/sumac)
- Photoallergens: sunscreen chemicals (oxybenzone), NSAIDs (ketoprofen), topical antibiotics
Pathophysiology
ICD: direct cytotoxic injury → barrier disruption → release of pro-inflammatory cytokines (IL-1, TNF-α). No sensitization required; severity dose-dependent. ACD: small molecule hapten penetrates skin, binds carrier protein, presented by Langerhans cells in regional lymph nodes → CD4+ T-cell sensitization (1-3 weeks); re-exposure → CD8+ memory T-cell mediated delayed hypersensitivity (24-72 hours) → eczematous response.
Clinical presentation
Symptoms
- ICD: burning, stinging, soreness; pruritus less prominent
- ACD: intense pruritus; sometimes burning
- Onset of ACD: 24-72 h after re-exposure in sensitized patient; ICD can occur within minutes to hours
Signs / physical exam
- Acute: erythema, edema, vesicles, weeping, crusting
- Subacute: erythematous scaly papules and plaques
- Chronic: lichenification, fissuring, hyperpigmentation
- Distribution matches exposure: linear streaks (poison ivy), earlobes/wrist/belt-line (nickel), hands (occupational), face/eyelids (cosmetics, nail polish transfer), scalp/hairline (hair dye), feet (shoe leather/rubber)
Classic findings
Sharp geometric or linear borders matching the contactant; eyelid involvement from airborne or transferred allergens is highly suggestive of ACD.
Differential diagnosis
- Atopic dermatitis — Personal/family atopy, flexural distribution, chronic course; AD predisposes to contact dermatitis
- Nummular dermatitis — Coin-shaped plaques without exposure history
- Tinea — Annular with central clearing and raised scaly border; KOH positive
- Cellulitis / erysipelas — Warm, tender, indurated; systemic symptoms; rapid spread; no vesicles
- Herpes zoster — Grouped vesicles in dermatomal distribution; prodromal pain
- Dyshidrotic eczema — Deep-seated tapioca-like vesicles on palms/soles/lateral fingers; pruritic
- Phytophotodermatitis — Streaky linear hyperpigmentation/blistering after lime/celery/citrus exposure + sun (psoralen + UV)
Diagnostic workup
Diagnostic criteria
Clinical pattern + temporal/spatial correlation with exposure; patch test confirms ACD allergen.
Labs
- Clinical diagnosis based on history and morphology
- Patch testing (gold standard for ACD): T.R.U.E. test or comprehensive panels (NACDG); read at 48 and 96-120 h
- Skin biopsy nonspecific (spongiotic dermatitis) — distinguishes from psoriasis or CTCL when atypical
Imaging
- Not indicated
Diagnostic algorithm
| Feature | Irritant (ICD) | Allergic (ACD) |
|---|---|---|
| Mechanism | Direct cytotoxic injury — non-immune | Type IV delayed hypersensitivity (T-cell) |
| Prior sensitization | Not required | Required (1-3 wk for first exposure) |
| Onset after exposure | Minutes to hours | 24-72 h (memory response) |
| Predominant symptom | Burning, stinging | Pruritus |
| Borders | Sharp, matches contactant | May extend beyond contact site (id reaction) |
| Diagnosis | Clinical + exposure history | Patch testing |
| Examples | Soap, solvents, wet work, urine/saliva | Nickel, fragrance, neomycin, urushiol, hair dye |
Treatment
First-line
- Identify and eliminate offending agent — single most important intervention
- Topical corticosteroid potency by site: hydrocortisone 1-2.5% (face, folds), triamcinolone 0.1% (trunk, extremities), clobetasol 0.05% (palms, soles, lichenified plaques) — 1-3 weeks
- Topical calcineurin inhibitor (tacrolimus, pimecrolimus) for face/eyelids/folds or steroid-sparing maintenance
- Cool compresses (Burow's solution/aluminum acetate) for acute weeping phase
- Emollients to restore barrier; gloves and barrier creams for occupational ICD
- Oral antihistamine (sedating, e.g., hydroxyzine) at night for sleep — minimal direct effect on itch
Severe / widespread / facial ACD (e.g., poison ivy)
- Oral prednisone 0.5-1 mg/kg/day tapered over 2-3 weeks (NOT a Medrol Dose Pack — rebound is common with short tapers <14 days)
- Short course IV/IM corticosteroid (e.g., triamcinolone IM) acceptable alternative
Chronic occupational hand dermatitis
- Job modification, gloves (vinyl/nitrile over cotton liners), barrier creams, frequent moisturizing
- Refractory: phototherapy (narrowband UVB, PUVA), oral alitretinoin (where available), dupilumab
Second-line / adjunct
- Antibiotic only if secondary bacterial infection — cephalexin, dicloxacillin
- Topical antipruritic: pramoxine, menthol
- Refer to occupational medicine for workers' compensation documentation
Complications
- Secondary bacterial infection (S. aureus, S. pyogenes)
- Post-inflammatory hyperpigmentation, especially Fitzpatrick IV-VI
- Chronic occupational hand dermatitis → job loss, disability
- Erythroderma in widespread severe cases
- Steroid-induced atrophy with prolonged high-potency topical use
PANCE pearls
- Linear streaky vesicles after hiking = poison ivy / oak / sumac (urushiol). The fluid in vesicles does NOT spread the rash; new lesions reflect different exposure doses absorbed at different rates.
- Eyelid dermatitis from nail polish (tosylamide formaldehyde resin) is classic — patient touches eyes with allergen-coated nails.
- Nickel patch testing is positive in ~15-20% of women and ~5% of men; the dimethylglyoxime spot test identifies nickel-releasing metal jewelry.
- Topical neomycin and bacitracin are common ACD culprits — avoid prophylactic 'triple antibiotic' on clean wounds; petrolatum is sufficient.
- Oral prednisone for poison ivy MUST be tapered ≥14-21 days; shorter courses cause rebound.
References
- AAD/ACDS 2020 — American Contact Dermatitis Society Core Allergen Series (Schalock et al., Dermatitis 2020)
- NACDG — North American Contact Dermatitis Group Patch-Test Results Periodic Reports (DeKoven et al., Dermatitis)
- AAD 2006 — Guidelines of Care for Contact Dermatitis (Bourke et al., J Am Acad Dermatol; updated reference standards)
Practice Dermatology questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.